TWST - Mergers and acquisitions

-- Accelerates Conversion from Microarray to Genotyping by Sequencing– -- Expands NGS Capabilities into New Markets -- Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the acquisition of iGenomX, a company offering multiplex library preparation tools for next-generation sequencing (NGS) workflows. The acquisition is expected to enhance Twist's capabilities to support multiplex sequencing preparations across multiple markets and to accelerate Twist's conversion of customers from static microarray platforms to genotyping by sequencing workflows. "The iGenomX te